View in EDS

Durvalumab: A Review in Limited-Stage Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Durvalumab: A Review in Limited-Stage Small Cell Lung Cancer.
Authors: France NL; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com., Syed YY; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Source: Targeted oncology [Target Oncol] 2026 Mar; Vol. 21 (2), pp. 299-307. Date of Electronic Publication: 2026 Mar 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41820709
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Durvalumab: A Review in Limited-Stage Small Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22France+NL%22">France NL</searchLink>; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.<br /><searchLink fieldCode="AU" term="%22Syed+YY%22">Syed YY</searchLink>; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2026 Mar; Vol. 21 (2), pp. 299-307. <i>Date of Electronic Publication: </i>2026 Mar 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41820709
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11523-026-01207-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 299
    Titles:
      – TitleFull: Durvalumab: A Review in Limited-Stage Small Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: France NL
      – PersonEntity:
          Name:
            NameFull: Syed YY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1776-260X
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Targeted oncology
              Type: main
ResultId 1